The Effectiveness of Montelukast on Atopic Dermatitis in Koreans
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical effectiveness of Montelukast in children
(2~6 years old) with atopic dermatitis and identify the pathophysiologic background of
Montelukast on the role of modulating the atopic dermatitis measured by urinary Leukotriene 4
(LTE4) and Eosinophil protein X(EDN).